NEW YORK (GenomeWeb) – Human Longevity will use imaging data from CorTechs Labs for the genomic and phenotypic database Human Longevity is building, the companies announced today.

CorTechs will provide quantitative evaluations of specially acquired magnetic resonance imaging data that will be integrated with other information from Human Longevity, including results from genome and microbiome sequencing, as well as metabolomics and proteomics data "to provide the most complete description of health ever assembled," the partners said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.